Edmond De Rothschild Holding S.A. Bei Gene, Ltd. Transaction History

Edmond De Rothschild Holding S.A.

$5.7 Billion
Q4 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 88,290 shares of BGNE stock, worth $20 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

88,290

Previous 103,890 15.02%

Holding current value

$20 Million

Previous $23.3 Million 30.08%

% of portfolio

0.29%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$174.72 - $246.04 $2.73 Million - $3.84 Million	-15,600 Reduced 15.02%	88,290 $16.3 Million
Q3 2024 Nov 13, 2024	BUY	$143.93 - $224.51 $1.58 Million - $2.47 Million	11,000 Added 11.84%	103,890 $23.3 Million
Q1 2024 May 08, 2024	BUY	$141.8 - $181.47 $1.55 Million - $1.98 Million	10,900 Added 13.29%	92,890 $14.5 Million
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $4.61 Million - $5.77 Million	25,610 Added 45.42%	81,990 $14.7 Million
Q2 2023 Aug 09, 2023	BUY	$178.3 - $266.78 $1.07 Million - $1.6 Million	6,000 Added 11.91%	56,380 $10.1 Million
Q1 2023 May 11, 2023	SELL	$215.53 - $274.5 $4.42 Million - $5.63 Million	-20,520 Reduced 28.94%	50,380 $10.9 Million
Q4 2022 Feb 09, 2023	BUY	$125.51 - $229.3 $376,530 - $687,900	3,000 Added 4.42%	70,900 $15.6 Million
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $351,219 - $626,545	2,900 Added 4.46%	67,900 $11 Million
Q1 2022 May 10, 2022	BUY	$146.52 - $269.56 $1.91 Million - $3.51 Million	13,010 Added 25.02%	65,000 $12.3 Million
Q4 2021 Feb 10, 2022	BUY	$248.56 - $389.34 $1.51 Million - $2.37 Million	6,090 Added 13.27%	51,990 $14.1 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $329,472 - $532,144	-1,320 Reduced 2.8%	45,900 $16.7 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $1.02 Million - $1.27 Million	3,473 Added 7.94%	47,220 $16.2 Million
Q1 2021 May 17, 2021	SELL	$260.64 - $382.12 $4.12 Million - $6.04 Million	-15,797 Reduced 26.53%	43,747 $15.2 Million
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $1.68 Million - $2.41 Million	-7,610 Reduced 11.33%	59,544 $15.4 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $1.4 Million - $2.12 Million	-7,390 Reduced 9.91%	67,154 $19.2 Million
Q2 2020 Aug 07, 2020	BUY	$123.9 - $195.41 $2.41 Million - $3.8 Million	19,424 Added 35.24%	74,544 $14 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $3.12 Million - $4.44 Million	25,620 Added 86.85%	55,120 $6.79 Million
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $3.42 Million - $6.15 Million	29,500 New	29,500 $4.89 Million

Others Institutions Holding BGNE

# of Institutions

251

Shares Held

45.6M

Call Options Held

322K

Put Options Held

144K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Bei Gene, Ltd. Transaction History